A study entitled “The oral microbiome in young women at different stages of periodontitis: Prevotella dominant in stage III periodontitis “ was recently published in Frontiers in Cellular and Infection Microbiology by Zhao et al. (2022). This study identified bacteria of the genus Prevotella as biomarkers of young women with stage-III periodontitis by 16S rRNA-sequencing (Zhao et al., 2022). We greatly appreciate this work and believe that the conclusion has potential value. However, we need to point out that the study protocol has some limitations, which may affect the accuracy of the conclusions.
First, only 26 young women with periodontitis were included in this study. We think that the small sample size will affect the ability to analyze alpha diversity analysis for the oral microbiome. Second, dysbiosis of oral microbial ecology is both a major causative factor for oral diseases such as periodontitis and is also closely associated with systemic diseases (Issrani et al., 2022; Xu et al., 2022). Therefore, Zhao and her colleagues excluded the group with systemic diseases, however they did not specify the methodology used to exclude systemic disease participants and did not perform detailed laboratory examinations on the individuals. It is well known that the range of systemic diseases is very broad (Bhuyan et al., 2022), and some of them have insidious clinical symptoms and are often overlooked by the patients themselves and their physicians. For example, the oral cavity and the intestine, two of the most complex microbial habitats in the body, are always interacting with each other. Numerous studies have shown that a variety of gastrointestinal diseases can alter the oral microbiota (Park et al., 2021; Abdelbary et al., 2022). For example, in H. pylori-positive patients, the oral microbiota is richer and more diverse than in H. pylori-negative patients, where Prevotella can reach 8.4%, second only to Streptococcus in terms of oral microbial abundance. In addition, viral infections such as HIV (Annavajhala et al., 2020) and HBV (Ling et al., 2015), metabolic diseases such as type 2 diabetes mellitus (Hajishengallis and Chavakis, 2021), metabolic dysfunction-associated fatty liver disease (Zeybel et al., 2022), and immune diseases such as rheumatoid arthritis (Kroese et al., 2021) can cause alterations in the composition of the host oral microbiota. Therefore, more detailed exclusion methods need to be given in the protocol, and the corresponding laboratory indicators need to be further refined for supporting evidence.
In addition, Zhao and her colleagues identified oral bacteria by amplification and sequencing of the V3-V4 region of 16S rDNA. Due to the possible limitations of this technology, sequencing the V3-V4 region of 16S rRNA can overlook species of tiny colonies and cannot reach taxonomic resolution of sparse bacterial populations at the species and strain levels. As a result, we recommend that sequencing analyses examining connections between oral microbiota and periodontitis stages should use full-length 16S intragenomic copy variations based on the V1-V9 rDNA sequence (Johnson et al., 2019). And we also found Zhao and her colleagues did qPCR to measure ER-stress via Col1A1-expression but did not confirm P. intermedia quantities by qPCR, which is a limitation. The quantitative results of P. intermedia are always best confirmed by qPCR. At the same time, colonization of the oral microbiota depends on the balance between microbial virulence host resistance, and bacterial symbiosis (Akimbekov et al., 2022). In this regard, we suggest further determination of the virulence factors of Prevotella, Porphyromonas and other critical bacteria, as they are likewise closely related to the mechanisms of periodontitis pathogenesis and progression (Aleksijević et al., 2022).
We believe that Zhao and her colleagues have made a great contribution to the pathogenesis of periodontitis in young women with stage III periodontitis. Nonetheless, because to the numerous factors regulating the oral microbiome, researchers must perform more extensive disease screening of participants and optimize testing modalities to further clarify which bacteria play a genuinely crucial role in young women with periodontitis.
Statements
Author contributions
WH and XT wrote the manuscript with the support from JB. The original idea was conceived by JB. All authors contributed to the article and approved the submitted version.
Funding
This work was funded by Biomedical Enterprise Project of Hangzhou Science and Technology Bureau (No. 2021WJCY186)
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbdelbaryM. M. H.HattingM.BottA.DahlhausenA.KellerD.TrautweinC.et al. (2022). The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Front. Cell Infect. Microbiol.12. doi: 10.3389/fcimb.2022.1010853
2
AkimbekovN. S.DigelI.YerezhepovA. Y.ShardarbekR. S.WuX.ZhaJ. (2022). Nutritional factors influencing microbiota-mediated colonization resistance of the oral cavity: A literature review. Front. Nutr.9. doi: 10.3389/fnut.2022.1029324
3
AleksijevićL. H.AleksijevićM.ŠkrlecI.ŠramM.ŠramM.TalapkoJ. (2022). Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases. Pathogens.11, 1173. doi: 10.3390/pathogens11101173
4
AnnavajhalaM. K.KhanS. D.SullivanS. B.ShahJ.PassL.KisterK.et al. (2020). Oral and gut microbial diversity and immune regulation in patients with HIV on antiretroviral therapy. mSphere.5, e00798–19. doi: 10.1128/mSphere.00798-19
5
BhuyanR.BhuyanS. K.MohantyJ. N.DasS.JulianaN.JulianaI. F. (2022). Periodontitis and its inflammatory changes linked to various systemic diseases: A review of its underlying mechanisms. Biomedicines.10, 2659. doi: 10.3390/biomedicines10102659
6
HajishengallisG.ChavakisT. (2021). Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat. Reviews: Immunol.21, 426–440. doi: 10.1038/s41577-020-00488-6
7
IssraniR.ReddyJ.DabahT. H. E.PrabhuN.AlruwailiM. K.MunisekharM. S.et al. (2022). Exploring the mechanisms and association between oral microflora and systemic diseases. Diagnostics (Basel).12, 2800. doi: 10.3390/diagnostics12112800
8
JohnsonJ. S.SpakowiczD. J.HongB. Y.PetersenL. M.DemkowiczP.ChenL.et al. (2019). Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat. Commun.10, 5029. doi: 10.1038/s41467-019-13036-1
9
KroeseJ. M.BrandtB. W.BuijsM. J.CrielaardW.LobbezooF.LoosB. G.et al. (2021). Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals. Arthritis Rheumatol.73, 1986–1993. doi: 10.1002/art.41780
10
LingZ.LiuX.ChengY.JiangX.JiangH.WangY.et al. (2015). Decreased diversity of the oral microbiota of patients with hepatitis b virus-induced chronic liver disease: A pilot project. Sci. Rep.5, 17098. doi: 10.1038/srep17098
11
ParkS. Y.HwangB. O.LimM.OkS. H.LeeS. K.ChunK. S.et al. (2021). Oral-gut microbiome axis in gastrointestinal disease and cancer. Cancers.13, 2124. doi: 10.3390/cancers13092124
12
XuX.XiaoJ.NiuY. (2022). Editorial: The pivotal role of oral microbiota dysbiosis and microbiota-host interactions in diseases. Front. Cell Infect. Microbiol.12. doi: 10.3389/fcimb.2022.947638
13
ZeybelM.ArifM.LiX.AltayO.YangH.ShiM.et al. (2022). Multiomics analysis reveals the impact of microbiota on host metabolism in hepatic steatosis. Adv. Sci. (Weinh).9, e2104373. doi: 10.1002/advs.202104373
14
ZhaoY.FengY.YeQ.HuJ.FengY.OuyangZ.et al. (2022). The oral microbiome in young women at different stages of periodontitis: Prevotella dominant in stage III periodontitis. Front. Cell Infect. Microbiol.12. doi: 10.3389/fcimb.2022.1047607
Summary
Keywords
periodontitis, 16S rRNA, Prevotella, Porphyromonas, systemic diseases
Citation
Huang W, Tang X and Bao J (2023) Commentary: The oral microbiome in young women at different stages of periodontitis: Prevotella dominant in stage III periodontitis. Front. Cell. Infect. Microbiol. 13:1141285. doi: 10.3389/fcimb.2023.1141285
Received
10 January 2023
Accepted
24 January 2023
Published
03 February 2023
Volume
13 - 2023
Edited by
Rosa Sessa, Sapienza University of Rome, Italy
Reviewed by
Georg Conrads, RWTH Aachen University, Germany
Updates
Copyright
© 2023 Huang, Tang and Bao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jianfeng Bao, hzxxbjf@outlook.com
This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.